HOMOGENEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING ABACAVIR, LAMIVUDINE AND ZIDOVUDINE - Patent 1083932

(19)

(11)

EP 1 083 932 A1

(12)

(43)	Date of publication:
	21.03.2001 Bulletin 2001/12

(21)	Application number: 99924822.2

(22)	Date of filing: 26.04.1999

(51)	International Patent Classification (IPC)⁷: A61K 47/02, A61K 31/70 // (A61K31/70, 31:52), A61K31:505

(86)	International application number:
	PCT/EP9902/794

(87)	International publication number:
	WO 9955/372 (04.11.1999 Gazette 1999/44)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

29.04.1998 GB 9809213

(71)	Applicant: GLAXO GROUP LIMITED
	Greenford, Middlesex UB6 ONN (GB)

(72)	Inventors:
	CURRIE, Robin Research Triangle Park, NC 27709 (US) JAIN, Sunil Research Triangle Park, NC 27709 (US) WOOD, Allen, Wayne Research Triangle Park, NC 27709 (US)

(74)	Representative: Crawley, Karen Anne et al
	Glaxo Wellcome plc,Glaxo Wellcome House,Berkeley Avenue Greenford,Middlesex UB6 0NN Greenford,Middlesex UB6 0NN (GB)

(54)	HOMOGENEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING ABACAVIR, LAMIVUDINE AND ZIDOVUDINE